10 newer rulings cite the same tariff codes.
Classification can shift over time. Review the more recent rulings below before relying on this one.
The tariff classification of Icatibant Acetate (CAS-138614-30-9), imported in bulk powder form, from Spain
Issued July 12, 2013 by U.S. Customs and Border Protection.
Cite this ruling
Copies to clipboardN2 N243161 (July 12, 2013)
Tariff classification
HTS codes: 2934.99.3000
Headings: 2934
Product description
The subject product, Icatibant Acetate, is a Bradykinin B2 receptor antagonist. It is indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older.
CBP rationale
The applicable subheading for the Icatibant Acetate imported in bulk powder form will be 2934.99.3000, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds: Other: Other: Aromatic or modified aromatic: Other: Drugs.
Full text
N243161 July 12, 2013 CLA-2-29:OT:RR:NC:N2:238 CATEGORY: Classification TARIFF NO.: 2934.99.3000 Ms. Inge Forstenzer Ren-Pharm International Ltd 350 Jericho Turnpike Suite 204 Jericho, NY 11753 RE: The tariff classification of Icatibant Acetate (CAS-138614-30-9), imported in bulk powder form, from Spain Dear Ms. Forstenzer: In your letter dated June 12, 2013, you requested a tariff classification ruling. The subject product, Icatibant Acetate, is a Bradykinin B2 receptor antagonist. It is indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older. The applicable subheading for the Icatibant Acetate imported in bulk powder form will be 2934.99.3000, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds: Other: Other: Aromatic or modified aromatic: Other: Drugs.” Pursuant to GN 13, HTSUS, the rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at http://www.usitc.gov/tata/hts/. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Judy Lee at (646) 733-3033. Sincerely, Thomas J. Russo Director National Commodity Specialist Division
More rulings on the same tariff codes
The tariff classification of Elinzanetant (CAS No. 929046-33-3) in bulk form and LYNKUET® (E linzanetant) Capsules in dosage form, from Germany
The tariff classification of Terazosin Hydrochloride Anhydrous (CAS No. 63074-08-8) in bulk form, from Germany
The tariff classification of Cabotegravir (CAS No. 1051375-10-0) in bulk powder form, from Brazil
The tariff classification of Ozanimod (CAS No. 1306760-87-1) in bulk form, from Taiwan
The tariff classification of Cabotegravir (CAS No. 1051375-10-0) in bulk powder form, from Brazil
The tariff classification of Aprepitant (CAS No. 170729-80-3) in bulk powder form, from Spain
The tariff classification of Brexpiprazole (CAS No. 913611-97-9) in bulk power form, from Taiwan
The tariff classification of Rivaroxaban (CAS No. 366789-02-8) in bulk powder form, from Mexico
The tariff classification of Prucalopride Succinate (CAS No. 179474-85-2) in bulk form, from India
The tariff classification of Ozanimod Hydrochloride (CAS No. 1618636-37-5), Brivaracetam (CAS No. 357336-20-0) and Tofacitinib Citrate (CAS No. 540737-29-9) in bulk form, from Taiwan
Follow N243161
Get an email if this ruling is revoked or modified, or a newer ruling supersedes it.
One email per day at most. Confirm your address once, unsubscribe anytime.
Searching CBP rulings the smart way
Rulings are precedent. See which ones apply to your product: TariffLens semantically searches all 200,000+ CBP rulings and builds defensible classifications backed by ruling citations.